1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61E5C36FD651F9FCF6525850C003CF5FD
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/1E5C36FD651F9FCF6525850C003CF5FD?OpenDocument
18
19OpenDocument
203.239.58.199
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Product Launch » Resource Allocation

Document Excerpt: Resourcing a Successful Product Launch: Investment Benchmarks

DB Image

Excerpt in Cart

ID: MD-697


Features:

5 Info Graphics

37 Data Graphics

520+ Metrics


Pages/Slides: 4


Published: 2020


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5597 "Resourcing a Successful Product Launch: Investment Benchmarks”.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Medical Device; Manufacturing; Consumer Products; Chemical; Biopharmaceutical


Companies Profiled:
Abbott; AbbVie; Agenus; Astellas; Baxter International; Bayer; Biogen; Boehringer Ingelheim; CSL Behring; Cutanea Life Sciences; Dicerna Pharmaceuticals; EMD Serono; Ferozsons Laboratories Limited; Ferring Pharmaceuticals; Genentech; GlaxoSmithKline ; Grünenthal; Inspire Pharmaceuticals; Ipsen; Lilly; Lundbeck; Lupin; Nektar Therapeutics; Novartis; Noven Pharmaceuticals; Novo Nordisk; OncoCyte; OTSUKA; Pharmacyclics; Regeneron; Roche; Santhera Pharmaceuticals; Sebela; Servier; Shire; Sunovion; Takeda Pharmaceuticals; Tesaro; Teva Pharmaceutical Industries Ltd; Zydus Cadila

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.